Harvard Bioscience (HBIO)DoD awarded $653K
DoD awarded Harvard Bioscience a contract with $653K committed so far.
- $653K
- committed so far
- Signed
- Jun 9, 2026
- Updated
- Jul 9, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 12, 2026Company filing · Form 8-K · ResultsReported its results
- Jun 2, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 2, 2026, the stockholders of Harvard Bioscience, Inc. (the “ Company ”) voted to approve the Amended and Restated 2021 Incentive Plan at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”
- Jun 9, 2026 · this disclosureFederal contract · $653K obligatedDepartment of Defense awarded HARVARD BIOSCIENCE INC: $653K obligated to date
What came next
- Jun 12, 2026Federal contract · $61K obligatedDepartment of Defense awarded HARVARD BIOSCIENCE INC: $61K obligated to date
- Jun 28, 2026Federal contract · $38K obligatedDepartment of Defense awarded HARVARD BIOSCIENCE INC: $38K obligated to date
- Jul 29, 2026Federal contract · $36K obligatedDepartment of Veterans Affairs awarded HARVARD BIOSCIENCE INC: $36K obligated to date
- Aug 11, 2026Company filing · Form 8-K · ResultsReported its results
- Sep 25, 2026Federal contract · $93K obligatedDepartment of Health and Human Services awarded HARVARD BIOSCIENCE INC: $93K obligated to date
- Sep 30, 2026Federal contract · $141K obligatedDepartment of Health and Human Services awarded HARVARD BIOSCIENCE INC: $141K obligated to date
How to read USAspending.gov award record
The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.
Full guide: Contract ceiling vs obligated amount: the difference
What else is on file for Harvard Bioscience
For Harvard Bioscience, OQRO holds 4 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HBIO page.
How this filing works
Other disclosures at Harvard Bioscience
- USAspending.gov award recordOct 5, 2026
- USAspending.gov award recordSep 30, 2026
- USAspending.gov award recordJul 29, 2026
- USAspending.gov award recordJul 28, 2026
- USAspending.gov award recordJun 12, 2026
- SEC Form 4Apr 1, 2026
Everything OQRO holds on this company is on its HBIO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
